Manulife (Manufacturers Life Insurance)’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,965
| Closed | -$555K | – | 2888 |
|
|
2026
Q1 | $555K | Sell |
13,965
-197,288
| -93% | -$5.05M | ﹤0.01% | 2112 |
|
|
2025
Q4 | $5.23M | Sell |
211,253
-50,893
| -19% | -$1.29M | ﹤0.01% | 1147 |
|
|
2025
Q3 | $6.36M | Sell |
262,146
-55,428
| -17% | -$985K | 0.01% | 1072 |
|
|
2025
Q2 | $4.17M | Buy |
317,574
+14,928
| +5% | +$189K | ﹤0.01% | 1246 |
|
|
2025
Q1 | $4.35M | Sell |
302,646
-14,683
| -5% | -$240K | ﹤0.01% | 1217 |
|
|
2024
Q4 | $5.32M | Buy |
317,329
+52,360
| +20% | +$867K | ﹤0.01% | 1177 |
|
|
2024
Q3 | $4.24M | Buy |
264,969
+124,075
| +88% | +$1.52M | ﹤0.01% | 1273 |
|
|
2024
Q2 | $1.27M | Buy |
140,894
+32,846
| +30% | +$312K | ﹤0.01% | 1716 |
|
|
2024
Q1 | $1.22M | Buy |
108,048
+45,027
| +71% | +$426K | ﹤0.01% | 1746 |
|
|
2023
Q4 | $502K | Hold |
63,021
| – | – | ﹤0.01% | 2167 |
|
|
2023
Q3 | $408K | Buy |
63,021
+5,600
| +10% | +$38.3K | ﹤0.01% | 2232 |
|
|
2023
Q2 | $355K | Hold |
57,421
| – | – | ﹤0.01% | 2252 |
|
|
2023
Q1 | $221K | Hold |
57,421
| – | – | ﹤0.01% | 2490 |
|
|
2022
Q4 | $185K | Hold |
57,421
| – | – | ﹤0.01% | 2604 |
|
|
2022
Q3 | $244K | Hold |
57,421
| – | – | ﹤0.01% | 2441 |
|
|
2022
Q2 | $287K | Hold |
57,421
| – | – | ﹤0.01% | 2428 |
|
|
2022
Q1 | $519K | Buy |
+57,421
| New | +$523K | ﹤0.01% | 2180 |
|
Manulife (Manufacturers Life Insurance)'s CNTA Position: Q2 2026 in Review
Manulife (Manufacturers Life Insurance) sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 13,965 shares — an estimated $555K sold.
Manulife (Manufacturers Life Insurance) first reported a position in CNTA in Q1 2022 and held it in 17 quarters. The position peaked at $6.36M in Q3 2025. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.
- Manulife (Manufacturers Life Insurance) reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 13,965 Centessa Pharmaceuticals shares in Q2 2026, an estimated $555K.
- Manulife (Manufacturers Life Insurance) first reported a position in Centessa Pharmaceuticals in Q1 2022 and held it in 17 quarters.
- Manulife (Manufacturers Life Insurance)'s Centessa Pharmaceuticals position peaked at $6.36M in Q3 2025.
- 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.